Skip to main content
Equibles

BARCLAYS PLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$79,168
+$5,490 QoQ
Shares Held
25,957
+58.5% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 162 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. LRMR ranks #256 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in LRMR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $79,168 25,957
2026-03-31 $73,678 16,373
2025-12-31 $298,970 78,470
2025-09-30 $228,984 70,893
2025-06-30 $245,244 84,860
2025-03-31 $116,656 54,259
2024-12-31 $272,544 70,425
2024-09-30 $393,209 60,032
2024-06-30 $103,319 14,251
2024-03-31 $138,168 18,204
2023-12-31 $160,574 35,291
2023-09-30 $19,868 5,030
2023-06-30 $169,746 54,232
2023-03-31 $128,167 28,293